UK Infected Blood Scandal: Inquiry to Expose Deep Failures
The upcoming report by the Infected Blood Inquiry is expected to highlight severe lapses in oversight and conflicts of interest that led to thousands of infections.
- Doctors involved in treating haemophilia had financial ties to pharmaceutical companies producing contaminated blood products.
- Evidence reveals UK government had been warned about the risks of infected blood products as early as the 1970s.
- Thousands were infected with HIV and hepatitis C through blood products, leading to over 3,000 deaths.
- Pharmaceutical companies and government officials ignored warnings and continued to use high-risk blood sources, including prisoners.
- The Infected Blood Inquiry's final report due next month is anticipated to be critical of the actions taken by both medical professionals and regulators.